These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 6810287

  • 21. [Influence of the inoculum effect on the MIC and MBC of 5 beta-lactams against Pseudomonas aeruginosa].
    Croize J, Le Noc P, Robert J.
    Pathol Biol (Paris); 1984 May; 32(5):412-4. PubMed ID: 6429613
    [Abstract] [Full Text] [Related]

  • 22. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
    Greenwood D, Eley A.
    J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
    [Abstract] [Full Text] [Related]

  • 23. In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.
    Perea EJ, Palomares JC, García-Iglesias MC.
    Chemotherapy; 1980 Jan; 26(4):282-8. PubMed ID: 6248300
    [Abstract] [Full Text] [Related]

  • 24. [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study].
    Quentin C, Auzerie J, Bebear C, Acar JF, Kitzis MD, Avril JL, Moillo-Batt A, Shacoori Z, Bergogne-Berezin E, Joly-Guillou ML.
    Pathol Biol (Paris); 1984 May; 32(5):301-6. PubMed ID: 6429608
    [Abstract] [Full Text] [Related]

  • 25. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC, Fu KP.
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [Abstract] [Full Text] [Related]

  • 26. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M, Brandimarte C, Santini C, Valente B, Martino P, Serra P.
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [Abstract] [Full Text] [Related]

  • 27. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R, Gutmann L, Kitzis MD, Goldstein F, Acar JF.
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [Abstract] [Full Text] [Related]

  • 28. [In vitro studies with piperacillin. Effectiveness against enterobacteriaceae and pseudomonas aeruginosa compared to other antibiotics (author's transl)].
    Baier R, Puppel H.
    Med Klin; 1979 Dec 14; 74(50):1923-7. PubMed ID: 120489
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E, Mark Z, Samra Y, Alkan M, Berger S.
    Chemioterapia; 1986 Apr 14; 5(2):75-82. PubMed ID: 2939966
    [Abstract] [Full Text] [Related]

  • 30. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
    Monteil H, Peladan F, Zinsius M.
    Presse Med; 1984 Mar 29; 13(13):780-4. PubMed ID: 6324160
    [Abstract] [Full Text] [Related]

  • 31. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
    Denis C, Lesage D, Delisle-Mizon F, Vergez P, Daguet GL.
    Pathol Biol (Paris); 1984 May 29; 32(5):415-20. PubMed ID: 6429614
    [Abstract] [Full Text] [Related]

  • 32. [Antibacterial spectrum of mezlocillin and MIC/disc correlations (author's transl)].
    Soussy CJ, Le Van Thoi J, Duval J.
    Nouv Presse Med; 1982 Feb 04; 11(5 Pt 2):309-13. PubMed ID: 6460965
    [Abstract] [Full Text] [Related]

  • 33. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K, Dickert H, Braveny I.
    Arzneimittelforschung; 1980 Feb 04; 30(2):304-7. PubMed ID: 6445735
    [Abstract] [Full Text] [Related]

  • 34. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H.
    Am J Med; 1986 Jun 30; 80(6B):126-37. PubMed ID: 3088998
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
    Schröter G, Schrettenbrunner A, Strenzel I.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb 30; 253(4):531-43. PubMed ID: 6407236
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Traub WH.
    Chemotherapy; 1982 Feb 30; 28(4):257-60. PubMed ID: 6288329
    [Abstract] [Full Text] [Related]

  • 39. In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
    Daschner FD, Steffens A, Mählmann M, Metzger M.
    Arzneimittelforschung; 1982 Feb 30; 32(5):531-3. PubMed ID: 6213241
    [Abstract] [Full Text] [Related]

  • 40. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
    Kosakai N, Oguri T.
    Jpn J Antibiot; 1980 Jun 30; 33(6):668-74. PubMed ID: 6779031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.